SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Mar 17, 2025

2. SEC Identification Number

39274

3. BIR Tax Identification No.

000-506-020-000

4. Exact name of issuer as specified in its charter

ACEN CORPORATION

5. Province, country or other jurisdiction of incorporation

Philippines

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

35th Floor, Ayala Triangle Gardens Tower 2, Paseo de Roxas corner Makati Avenue Postal Code 1226

8. Issuer's telephone number, including area code

77306300

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common Shares	39,677,394,773
Series A Preferred Shares	8,341,500
Series B Preferred Shares	16,658,500

11. Indicate the item numbers reported herein

Item 9 - Other Events

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

ACEN CORPORATIONACEN

PSE Disclosure Form 4-2 - Acquisition/Disposition of Shares of Another Corporation
References: SRC Rule 17 (SEC Form 17-C) and
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Subscription by the Company to additional shares in Buendia Christiana Holdings Corp.
Background/Description of the Disclosure
The Company, ACEN CORPORATION ("ACEN"), signed a subscription agreement with its subsidiary, Buendia Christiana Holdings Corp. ("BCHC"), for the subscription by ACEN to 660,000 common shares and 5,940,000 redeemable preferred shares (“RPS”), to be issued out of the authorized capital stock of BCHC.

Date of Approval by Board of Directors	Aug 18, 2020

Rationale for the transaction including the benefits which are expected to be accrued to the Issuer as a result of the transaction
The additional capital will be used by BCHC to purchase real property required for various potential power projects.

Details of the acquisition or disposition

Date	Mar 17, 2025

Manner
Subscription to common shares and RPS
Description of the company to be acquired or sold
BCHC is a subsidiary of ACEN, and is a special purpose vehicle, which will own land for the Company’s development projects.

The terms and conditions of the transaction

Number of shares to be acquired or disposed	6,600,000
Percentage to the total outstanding shares of the company subject of the transaction	13
Price per share	Php 100.00 - common; Php 100.00 - RPS

Nature and amount of consideration given or received
Total Subscription Price of Php660,000,000
Principle followed in determining the amount of consideration
Subscription at par value
Terms of payment
Full payment in cash
Conditions precedent to closing of the transaction, if any
Subject to the necessary regulatory approval by the SEC of the increase in authorized capital stock of BCHC
Any other salient terms
None

Identity of the person(s) from whom the shares were acquired or to whom they were sold

Name	Nature of any material relationship with the Issuer, their directors/ officers, or any of their affiliates
Buendia Christiana Holdings Corp.	Subsidiary of the Company

Effect(s) on the business, financial condition and operations of the Issuer, if any
The figure under “Percentage to the total outstanding shares of the company subject of the transaction” assumes SEC approval of the increase in BCHC’s authorized capital stock. The 6,600,000 shares to be acquired is made up of 660,000 common shares and 5,940,000 RPS.
Other Relevant Information
-